# Supernus Pharmaceuticals (SUPN): value investors who own it

1 value investor held Supernus Pharmaceuticals in their Q3 2026 13F, led by Third Avenue Management.

## 13F holders

| Manager | Portfolio | Value | Change | Quarters held |
| --- | --- | --- | --- | --- |
| Third Avenue Management | 1.1% | $7.1m | Unchanged | 17 |

## Fund holders

| Fund | Manager | Weight | Value | As at |
| --- | --- | --- | --- | --- |
| Third Avenue Small-Cap Value Fund | Third Avenue Management | 3.2% | $7.0m | 2026-07-31 |

Source: SEC filings, via moatshark (https://www.moatshark.com/s/supn). Values traded and returns are estimates. Not investment advice. Built 2026-10-21.